These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 11741801)

  • 1. [PTHrP and breast cancer].
    Devys A; Lortholary A; Audran M
    Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases.
    Bouizar Z; Spyratos F; Deytieux S; de Vernejoul MC; Jullienne A
    Cancer Res; 1993 Nov; 53(21):5076-8. PubMed ID: 8221637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P
    Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis.
    Wysolmerski JJ; Dann PR; Zelazny E; Dunbar ME; Insogna KL; Guise TA; Perkins AS
    J Bone Miner Res; 2002 Jul; 17(7):1164-70. PubMed ID: 12096830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
    de Vernejoul MC
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
    [No Abstract]   [Full Text] [Related]  

  • 10. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
    Bouizar Z; Spyratos F; De vernejoul MC
    J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related protein.
    Moseley JM; Gillespie MT
    Crit Rev Clin Lab Sci; 1995; 32(3):299-343. PubMed ID: 7495499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parathyroid hormone related peptide (PTHrP) and bone metabolism].
    Rouffet J; Barlet JP
    Arch Physiol Biochem; 1995 Apr; 103(1):3-13. PubMed ID: 8574773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel parathyroid hormone-related protein: role in pathology and physiology.
    Martin TJ; Ebeling PR
    Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
    Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
    Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of parathyroid hormone-related protein and its receptor in breast carcinoma: a potential autocrine effector system.
    Iezzoni JC; Bruns ME; Frierson HF; Scott MG; Pence RA; Deftos LJ; Bruns DE
    Mod Pathol; 1998 Mar; 11(3):265-70. PubMed ID: 9521473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer bone metastasis and current small therapeutics.
    Cicek M; Oursler MJ
    Cancer Metastasis Rev; 2006 Dec; 25(4):635-44. PubMed ID: 17160709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.